Dowden Nathan J (CIK 0001873392)

Latest company ownership

TRDA - Entrada Therapeutics, Inc.

Role: COO

Shares held

179,059

Last filed at

Sep 4, 2025

Confidence Score

50.5

2025Q4

Confidence Score History

2022Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Sep 2, 2025	Sep 4, 2025	Entrada Therapeutics, Inc.	COO	Sell	50.0	-1,746	-0.97%	✗	$9.5K
Mar 1, 2025	Mar 4, 2025	Entrada Therapeutics, Inc.	COO	Sell	95.0	+55,656	44.47%	✗	$60.1K
Sep 26, 2024	Sep 30, 2024	Entrada Therapeutics, Inc.	COO	Sell	51.3	-847	-0.67%	✓	$13.6K
Sep 6, 2024	Sep 10, 2024	Entrada Therapeutics, Inc.	COO	Sell	48.8	-2,303	-1.80%	✓	$34.8K
Sep 3, 2024	Sep 5, 2024	Entrada Therapeutics, Inc.	COO	Sell	46.3	-1,808	-1.39%	✗	$28.3K
Aug 16, 2024	Aug 20, 2024	Entrada Therapeutics, Inc.	COO	Sell	17.5	-27,097	-17.24%	✓	$440.8K
Mar 6, 2024	Mar 8, 2024	Entrada Therapeutics, Inc.	COO	Sell	48.8	-1,826	-1.31%	✓	$22.5K
Mar 1, 2024	Mar 5, 2024	Entrada Therapeutics, Inc.	COO	Sell	91.3	+90,862	188.64%	✗	$28K
Sep 1, 2023	Sep 6, 2023	Entrada Therapeutics, Inc.	COO	Sell	91.3	+12,792	36.16%	✓	$19.4K
Jul 10, 2023	Jul 12, 2023	Entrada Therapeutics, Inc.	COO	Sell	20.0	-7,097	-16.71%	✓	$127.9K
Jun 20, 2023	Jun 22, 2023	Entrada Therapeutics, Inc.	COO	Sell	10.0	-15,982	-27.34%	✓	$246.4K
Mar 1, 2023	Mar 3, 2023	Entrada Therapeutics, Inc.	COO	Sell	91.3	+27,372	60.45%	✗	$11.9K
Oct 31, 2022	Nov 2, 2022	Entrada Therapeutics, Inc.	COO	Sell	37.5	-2,100	-4.43%	✓	$50.5K
Oct 25, 2022	Oct 27, 2022	Entrada Therapeutics, Inc.	COO	Sell	20.0	-9,348	-16.48%	✓	$194.2K
Oct 20, 2022	Oct 24, 2022	Entrada Therapeutics, Inc.	COO	Sell	28.8	-6,080	-9.68%	✓	$113.4K
Sep 26, 2022	Sep 28, 2022	Entrada Therapeutics, Inc.	COO	Sell	45.0	-1,544	-2.40%	✓	$23.9K
Sep 21, 2022	Sep 23, 2022	Entrada Therapeutics, Inc.	COO	Sell	32.5	-4,293	-6.25%	✓	$64.9K
Sep 15, 2022	Sep 19, 2022	Entrada Therapeutics, Inc.	COO	Sell	55.0	-100	-0.15%	✓	$1.5K
Sep 8, 2022	Sep 12, 2022	Entrada Therapeutics, Inc.	COO	Sell	45.0	-1,777	-2.52%	✓	$26.8K
Jun 27, 2022	Jun 29, 2022	Entrada Therapeutics, Inc.	COO	Sell	25.0	-7,714	-10.62%	✓	$100.3K